Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology
D J CampbellS B Harrap

Abstract

When spontaneously hypertensive rats (SHR) treated at a young age with an inhibitor of angiotensin-converting enzyme (ACE) are withdrawn from treatment, their blood pressure (BP) remains below that of untreated rats. We examined the effects of ACE inhibitor treatment and its withdrawal on angiotensin-(1-7) [Ang-(1-7)], angiotensin II (Ang II) and angiotensin I (Ang I) in plasma, kidney, adrenal, heart, aorta, brown adipose tissue, lung, and brain of male SHR and normotensive Donryu rats. Rats were administered either vehicle or perindopril (3 mg/kg/day) from 6 to 10 weeks, from 6 to 20 weeks, and from 6 to 10 weeks, followed by perindopril withdrawal from 10 to 20 weeks. Angiotensin peptides and plasma levels of renin, angiotensinogen, ACE, and aldosterone were measured at 10 and 20 weeks of age. Perindopril reduced BP of both SHR and Donryu rats, although only SHR showed a reduction of BP of 19 mm Hg after perindopril withdrawal, associated with a reduction of 5% in heart weight/body weight ratio. Perindopril reduced the angiotensin II/angiotensin I ratio in all tissues by > 50%, with strain- and tissue-specific differences in the effects of perindopril on the levels of individual angiotensin peptides. None of the changes in A...Continue Reading

Citations

Jul 17, 1999·European Journal of Pharmacology·H AiharaS Satoh
May 1, 1997·The Journal of Laboratory and Clinical Medicine·E P CohenJ E Moulder
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Stefan EngeliArya M Sharma
Sep 4, 1999·Clinical and Experimental Pharmacology & Physiology·J IbrahimP S Sever
Apr 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Anura P JayasooriyaRichard S Weisinger
Apr 10, 2004·Current Opinion in Nephrology and Hypertension·Pasquale Strazzullo, Ferruccio Galletti
Dec 20, 2007·Current Opinion in Nephrology and Hypertension·Marcelo Alves-da-Silva MoriJoão Bosco Pesquero
Dec 18, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takayuki KawamuraMasahiro Kohzuki
Apr 22, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Michelle J PorrittDavid W Howells
Jan 15, 2008·Physiology & Behavior·Harrison S WeisingerRichard S Weisinger
May 14, 2011·British Journal of Pharmacology·Reza AghamohammadzadehAnthony Heagerty
Apr 14, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·E VelkoskaM J Morris
Nov 21, 2007·Diabetes·Sérgio Henrique S SantosRobson Augusto S Santos
Aug 21, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·F J ChavesJ Redon
Oct 2, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jennifer Manning, V Matti Vehaskari
Aug 3, 2002·Hypertension·Saraswati PokharelYigal M Pinto
Sep 22, 2001·Hypertension·S B Harrap, Y Ohno
Jan 9, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Giancarla A Botelho-SantosRobson A Souza dos Santos
Jun 12, 2009·Journal of Hypertension·Robert M K W LeeYu-Jing Gao
Oct 3, 1999·Physiological Reviews·J Zicha, J Kunes
Mar 1, 2003·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·G H GoossensM A van Baak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.